Marat Fudim, MD MHS
@FudimMarat
Duke Cardiology, 🇺🇦+🇩🇪+🇺🇸, #HeartFailure. Views expressed are my own and do not reflect the views or opinions of my employer.
ID:716472149213634560
03-04-2016 03:47:26
3,4K Tweets
4,1K Followers
981 Following
New Study with Marat Fudim, MD MHS Abdul Mannan Khan Minhas
In a national examination of COVID patients
⬆️Cardiac Comorbidities (HF, AF, CAD, PVD, DM, prior stroke) associated with ⬆️Mortality and ⬆️IMV with stepwise increase in risk for each additional comorbidity.
journals.plos.org/plosone/articl…
The time to act is…yesterday. So many great options to improve #HeartFailure outcomes but THIS is the reality 😩😩😩
Cutting Edge Device Therapy for HF #AHFS24
Managing MR, AF/HF, Interventional considerations
Brett Atwater Wayne Batchelor, MD Joann Lindenfeld
Christopher O'Connor
The future is bright for those afflicted with cardiac amyloidosis!
Happy to have spoken about the state of available and emerging therapies for AL and ATTR cardiomyopathy today Inova Schar Heart and Vascular HF and Shock symposium.
Inova HF symposium continues - Great review from Marat Fudim, MD MHS on both the state of the evidence for iron repletion in HF + real world breakdown of challenges to implementation - big gap between placing an order and truly addressing iron deficiency Inova Schar Heart and Vascular
Outstanding start to the day at the Inova Schar Heart and Vascular Inova Advanced Heart Failure and Shock Symposium - Shashank Sinha, MD, MSc, FACC, FAHA and Vanessa Blumer, MD, FACC on state of the art phenotyping and device selection- more talks upcoming from A. Reshad Garan MD , Ann Gage, Manreet Kanwar, Ran Lee , Behnam N. Tehrani, MD
Excellent overview of the role of iron therapy in patients with HF by Marat Fudim, MD MHS at the Inova Schar Heart and Vascular AHF and shock symposium! Christopher O'Connor
Outstanding update on Drug Therapy for AHF #AHFS24 Peter Carson - Latest on treating HFpEF
Sumeet Singh Mitter, MD, MSc -- Managing Amyloid
Marat Fudim, MD MHS -- Role of Iron
BiykemBozkurt -- Review of Statistics on Outcomes
Christopher O'Connor
Phenomenal discussion by Vishal Rao detailing his approach to integrating research into CV fellowships! Such amazing insights! Highly recommended for any training program! MUSC-CardiologyFellowshipPrograms MUSC Health Marat Fudim, MD MHS Robert Mentz, MD
We're honored to partner with Drs. Marat Fudim, MD MHS, Chandler Long, Adam DeVore, MD, MHS and Dennis Abraham and the team at Duke University Hospital on their first #Barostim implant. Thanks for providing a novel therapy option for your #heartfailure patients.
US heart failure deaths in 2021 reached levels not seen since 1999
healio.com/news/cardiolog…
JAMA Cardiology Marat Fudim, MD MHS Ahmed Sayed Javed Butler
How have HF mortality rates changed from 1999-2021 in the US?
From 1999-2012
↘ : Decline by ~25%
From 2012-2021
↗ Reversals that have now undone ALL initial declines.
🚨HF mortality in 2021 > HF mortality in 1999 🚨
jamanetwork.com/journals/jamac…
Marat Fudim, MD MHS Ahmed Sayed HFSA
Tom Sarma UT Southwestern Medical Center giving great visiting cardiology grand rounds on HFpEF physiology and the multi-organ failure and treatment pathways. Duke Heart Marat Fudim, MD MHS Nishant Shah, MD Jennifer Rymer
This paper highlights important background information, anatomical considerations, therapeutic options & future directions regarding tricuspid valve disease.
✍🏽 @GeorgeDangas Dr. Gilbert Tang Edwin Ho Marat Fudim, MD MHS Midge B DNP, FAANP, FAAN Pavan Atluri Prof Jason Kovacic Tiberio Frisoli
📖Circulation